Stockreport

Nephros Announces Pricing of $7.5 Million Underwritten Offering of Common Stock

Nephros, Inc.  (NEPH) 
NASDAQ:AMEX Investor Relations: nephros.com/investor-relations
PDF SOUTH ORANGE, NJ, Jan. 31, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nephros, Inc. (Nasdaq: NEPH) (“Nephros” or the “Company”), a  commercial-stage company that deve [Read more]